Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities
Net loss	$ (1,954)	$ (9,182)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	1,295	1,134
Operating lease right-of-use assets expense	1,420	1,749
Foreign currency remeasurement loss (gain)	580	(175)
Stock-based compensation	9,458	8,104
Deferred income taxes	(72)	(82)
Other	(146)	(1,566)
Change in value of earn-out and warrant liabilities	(1,490)	109
Changes in operating assets and liabilities:
Accounts receivable	10,933	10,049
Prepaid expenses and other current assets	1,718	3,571
Deferred contract costs and other assets	4,447	2,987
Accounts payable, accrued expenses, operating lease liabilities and other liabilities	(14,293)	(12,828)
Deferred revenue	(4,140)	(2,620)
Net cash provided by operating activities	7,756	1,250
Investing activities
Maturities of investments	240	1,670
Purchases of investments	(389)	(74)
Capitalization of internal-use software	(391)	(259)
Purchase of property and equipment	(502)	(225)
Investment in notes	(500)	(250)
Net cash (used in) provided by investing activities	(1,542)	862
Financing activities
Repurchase of common stock	(13,743)	(1,811)
Proceeds from stock option exercises	784	1,131
Repayments of finance leases	(2)	(10)
Net cash used in financing activities	(12,961)	(690)
Effect of exchange rates on cash	(926)	217
Net (decrease) increase in cash and cash equivalents	(7,673)	1,639
Cash and cash equivalents at beginning of period	223,162	227,188
Cash and cash equivalents at end of period	215,489	228,827
Supplemental disclosures of cash flow information
Income taxes paid	984	327
Unpaid redemption of noncontrolling interest	$ 5,926	$ 0